Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-04-03 | New | $90,001,086 | $90,001,086 | Equity Only | 06b | SEC link |
| 2019-03-29 | New | $44,099,096 | $44,099,096 | Equity Only | 06b | SEC link |
| 2016-04-21 | New | $6,000,000 | $6,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Christoph M. Adams | Executive |
| Mette Kirstine Agger | Director |
| Rahul Ballal | Director |
| Jake Bauer | Director |
| David Bonita | Director |
| Mark Chin | Director |
| Helen Collins | Executive |
| Barbara Dalton | Director |
| Mika Derynck | Director |
| Carl Goldfischer | Director |
| Rishi Gupta | Director |
| Richard Heyman | Director |
| Benjamin Hohl | Executive |
| Robert Hopfner | Director |
| Samuel Kintz | Director, Executive |
| Joseph P. Lyssikatos | Director, Executive |
| James G. Mc Arthur | Director |
| David Mott | Director |
| Sara Nayeem | Director |
| Anish Patel | Executive |
| Andrew Phillips | Director |